Cepheid
Bob Bliss currently serves as the Senior Director of Instrument Operations Planning and Platform Management at Cepheid since June 2023, where responsibilities include leading cross-functional operations and supply chain teams to enhance existing products and launch new ones. Prior to this role, Bob held the position of Senior Director of Global Demand Planning at Cepheid from November 2019 to March 2023, managing a team focused on demand planning, global master scheduling, and inventory management. Previous experience includes leadership roles at Tesla, Logitech, and Hewlett Packard, where achievements involved production planning, supply chain management, and driving analytical methodologies to improve operational performance. Bob holds an MBA in Operations Research and multiple engineering degrees from prestigious institutions, including MIT and Stanford.
This person is not in any teams
This person is not in any offices
Cepheid
10 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.